Accurate targeting of daily intravenous busulfan with 8-hour blood sampling in hospitalized adult hematopoietic cell transplant recipients.

Yeh, Rosa F; Pawlikowski, Matthew A; Blough, David K; McDonald, George B; O'Donnell, Paul V; Rezvani, Andrew; Deeg, H Joachim; McCune, Jeannine S

Yeh, Rosa F; Pawlikowski, Matthew A; Blough, David K; McDonald, George B; O'Donnell, Paul V; Rezvani, Andrew; Deeg, H Joachim; McCune, Jeannine S.

Affiliation

Yeh RF; Seattle Cancer Care Alliance Pharmacokinetics Laboratory, 825 Eastlake Ave. E, Seattle, WA 98109, USA. ryeh@seattlecca.org

Biol Blood Marrow Transplant ; 18(2): 265-72, 2012 Feb.

Article in En | MEDLINE | ID: mdl-21736869

Subject(s)

Busulfan/administration & dosage; Busulfan/pharmacokinetics; Hematologic Neoplasms/therapy; Hematopoietic Stem Cell Transplantation; Myeloablative Agonists/administration & dosage; Myeloablative Agonists/pharmacokinetics; Transplantation Conditioning; Adult; Aged; Antineoplastic Agents/administration & dosage; Antineoplastic Agents/pharmacokinetics; Cyclophosphamide/administration & dosage; Cyclophosphamide/pharmacokinetics; Female; Humans; Injections, Intravenous; Male; Middle Aged; Retrospective Studies; Transplantation, Homologous; Vidarabine/administration & dosage; Vidarabine/adverse effects; Vidarabine/analogs & derivatives

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Busulfan / Hematopoietic Stem Cell Transplantation / Hematologic Neoplasms / Transplantation Conditioning / Myeloablative Agonists Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2012 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google